Practical guidelines for the treatment of cholera

Drugs

Volumn 51, Issue 6, 1996, Pages 966-973

  Seas, Carlos ^a   Dupont, Herbert L ^b,c,d   Valdez, Luis M ^a,c   Gotuzzo, Eduardo ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d MC 1 164 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; FURAZOLIDONE; NORFLOXACIN; ORAL REHYDRATION SOLUTION; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TETRACYCLINE;

ANTIMICROBIAL THERAPY; CHOLERA; DEHYDRATION; ELECTROLYTE BALANCE; FLUID INTAKE; FLUID THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; ORAL REHYDRATION THERAPY; REVIEW;

EID: 0029883230     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199651060-00005     Document Type: Review

References (24)

1. Albert MJ, Ansaruzzaman M, Bardhan PK, et al. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae 0139 synonym Bengal. Lancet 1993; 342 (8868): 387-90
2. Wachsmuth IK, Evins GM, Fields PI, et al. The molecular epidemiology of cholera in Latin America. J Infect Dis 1993; 167: 621-6
3. Swerdlow DL, Ries AA. Vibrio cholerae non 01 - the eighth pandemic? Lancet 1993; 342: 382-3
4. Cholera in 1991. Wkly Epidemiol Rec 1992; 67: 253-60
5. Bennish ML. Cholera: pathophysiology, clinical features, and treatment. In: Wachsmuth K, Blake PA, Olsvik Æ, editors. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology. 1994: 229-55
6. Gangarosa EJ, Mosley WH. Epidemiology and surveillance of cholera. In: Barua D, Burrows W, editors. Cholera. Philadelphia: Saunders, 1974: 381-403
7. Battacharya SK, Battacharya MK, Nair GB, et al. Clinical profile of acute diarrhoea cases infected with the new epidemic strain of Vibrio cholerae 0139: designation of the disease as cholera. J Infect 1993; 27: 11-5
8. Cieza J, Gamarra G, Torres C, et al. Expansion endovenosa rapida con cloruro de sodio a10.9% en pacientes adultos moderada y severamente deshidratados por colera. Rev Med Herediana 1991; 2: 57-63
9. Gotuzzo E, Cieza J, Estremadoyro L, et al. Cholera: lessons from the epidemic in Peru. Infect Dis Clin North Am 1994; 8: 183-205
10. Rabbani GH, Greenough III WB. Pathophysiologv and clinical aspects of cholera. In: Barua D, Greenough III WB, editors. Cholera. New York: Plenum Medical Book Co., 1992: 209-28
11. Miyahira J, Acosta R, Zurita S, et al. Insuficiencia renal aguda en el Hospital Nacional Cayetano Heredia. Rev Med Herediana 1991; 2: 64-9
12. Cieza J. Esquema para el manejo de pacientes deshidratados por colera. Rev Med Herediana 1991; 2: 85-8
13. World Health Organization. Management of the patient with cholera. Geneva: World Health Organization, Programme for Control of Diarrhoeal Disease, 1991. Publication WHO/ CDD/SER/91.15, 1991
14. Kaper JB, Morris JG, Levine MM. Cholera. Clin Microbiol Rev 1995; 8: 48-86
15. Fukuda JM, Yi A, Chaparro L, et al. Clinical characteristics and risk factors for Vibrio cholerae infection in children. J Pediatr 1995; 126: 882-6
16. Hirschhorn N, Greenough III WB. Progress in oral rehydration therapy. Sci Am 1991; 264: 50-6
17. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta analysis of 13 clinical trials. BMJ 1992; 304: 287-91
18. Greenough III WB, Gordon RS, Rosenberg IS, et al. Tetracycline in the treatment of cholera. Lancet 1964; I: 355-7
19. Alam AN, Alum NH, Ahmed T, et al. Randomised double blind trial of single dose doxycycline for treating in adults. BMJ 1990; 300: 1619-21
20. Mhalu FS, Mmari PW, Ijumba J. Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet 1979; I: 345-7
21. Glass RI, Huq Y, Alim AR, et al. Emergence of multiple antibiotic-resistant Vibrio cholerae in Bangladesh. J Infect Dis 1980; 142: 939-42
22. Battacharya SK, Bhattacharya MK, Dutta P, et al. Double-blind randomized, controlled clinical trial of norfloxacin for cholera. Antimicrob Agents Chemother 1990; 34: 939-40
23. Gotuzzo E, Seas C, Echevarria J, et al. Ciprofloxacin for the treatment of cholera: a randomized, double-blinded, controlled clinical trial of a single daily dose in Peruvian adults. Clin Infect Dis 1995; 20: 1485-90
24. Ghosh S, Sengupla PG, Gupta DN, et al. Chemoprophylaxis studies in cholera: a review of selective works. J Commun Dis 1992; 24: 55-7